Research programme: serotonin/histamine antagonists - Evolutec

Drug Profile

Research programme: serotonin/histamine antagonists - Evolutec

Alternative Names: EV 598; rEV 598

Latest Information Update: 19 Mar 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Evolutec
  • Class Antiemetics; Antineoplastics; Glycoproteins
  • Mechanism of Action Histamine release inhibitors; Serotonin receptor antagonists; Serotonin release inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Malignant carcinoid syndrome; Nausea and vomiting

Most Recent Events

  • 25 Oct 2006 Suspended - Preclinical for Emesis in United Kingdom (Parenteral)
  • 14 Mar 2006 EV 598 is available for licensing (http://www.evolutec.co.uk)
  • 05 Sep 2005 This compound is still in active development - (BIO-2005)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top